Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities.

Cornel Pater, Hannover, Germany. drcornelpater@aol.com.

PMID: 15691384 [PubMed - as supplied by publisher]

PMCID: PMC549209

LinkOut - more resources

Review[Clinical trials using antidepressants and antipsychotics. The pros and cons of placebo control]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 May; 48(5):541-7.

[Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005]
ReviewWITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee.
Cochrane Database Syst Rev. 2007 Jul 18; (1):CD000142. Epub 2007 Jul 18.

[Cochrane Database Syst Rev. 2007]
ReviewPlant-derived compounds in clinical trials.
Drug Discov Today. 2008 Feb; 13(3-4):161-71. Epub 2007 Nov 26.

[Drug Discov Today. 2008]
ReviewClinical considerations in developing dendritic cell vaccine based immunotherapy protocols in cancer.
Curr Mol Med. 2009 Aug; 9(6):725-31.

[Curr Mol Med. 2009]
Quality of life as an endpoint in Phase I oncology clinical trials of novel chemotherapy drugs.
Expert Rev Pharmacoecon Outcomes Res. 2005 Oct; 5(5):633-44.

[Expert Rev Pharmacoecon Outcomes Res. 2005]
» See reviews... | » See all...

Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC

Your browsing activity is empty.

Activity recording is turned off.